Sangamo and Pfizer Focus on Translating Genomic Medicines Using Gene Therapy

Sangamo and Pfizer announced their focus on translating genomic medicines using gene therapy for severe hemophilia A has shown promising results. Shares in $SGMO and $PFE reacted positively to the news.